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Histamine is a neurotransmitter involved in a number of physiological and neuronal
functions. In mammals, such as humans, and rodents, the histaminergic neurons
found in the tuberomamillary nucleus project widely throughout the central nervous
system. Histamine acts as positive modulator of GABAA receptors (GABAARs) and,
in high concentrations (10 mM), as negative modulator of the strychnine-sensitive
glycine receptor. However, the exact molecular mechanisms by which histamine acts
on GABAARs are unknown. In our study, we aimed to identify amino acids potentially
involved in the modulatory effect of histamine on GABAARs. We expressed GABAARs
with 12 different point mutations in Xenopus laevis oocytes and characterized the
effect of histamine on GABA-induced currents using the two-electrode voltage clamp
technique. Our data demonstrate that the amino acid residues β2(N265) and β2(M286),
which are important for modulation by propofol, are not involved in the action of
histamine. However, we found that histamine modulation is dependent on the amino
acid residues α1(R120), β2(Y157), β2(D163), β3(V175), and β3(Q185). We showed
that the amino acid residues β2(Y157) and β3(Q185) mediate the positive modulatory
effect of histamine on GABA-induced currents, whereas α1(R120) and β2(D163) form a
potential histamine interaction site in GABAARs.
Keywords: GABAAR, histamine, modulation, site-directed mutagenesis, potentiation, salt-bridge
Introduction
The GABAA receptor (GABAAR) is the most important inhibitory receptor channel complex in
the central nervous system (CNS). It is a pentameric ligand-gated ion channel, which is activated
by γ-aminobutyric acid (GABA) and is modulated by various compounds. GABAAR modulators
include benzodiazepines, barbiturates, propofol, ethanol, neurosteroids, cations (e.g., zinc ions),
herbal components and odorants as well as the neurotransmitter histamine (Bureau and Olsen,
1991; McDonald and Olsen, 1994; Thompson et al., 1996; Grobin et al., 1998; Hosie et al., 2003;
Kim and McDonald, 2003; Belelli and Lambert, 2005; Li et al., 2006; Saras et al., 2008; Sergeeva
et al., 2010; Rudolph and Knoﬂach, 2011; Kletke et al., 2013; Yip et al., 2013). Since 2008, it has
been known that histamine could directly activate homomeric GABAARs composed of β subunits
and modulate the heteromeric GABAARs α1β2 and α1β2γ2 (Saras et al., 2008). The modulatory
eﬀects of histamine on heteromeric GABAARs depend on the subunit composition of the receptors
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(Bianchi et al., 2011). Today, 19 subunits are known (Simon et al.,
2004). These subunits are α1–6, β1–3, γ1–3, δ, ε, θ, π, and ρ1–3.
Bianchi et al. (2011) showed α subunit preference of histamine
under low GABA concentrations.
Histamine is a neurotransmitter in the brain and a cytokine
in the periphery. It is produced and released by mast cells,
basophiles, enterochromaﬃn-like cells, and neurons (Haas
et al., 2008). In the brain histamine is released from the
tuberomammillary nucleus which is involved in the wake-
sleep regulation. Metabotropic histamine receptors (H1–H4)
mediate the physiological functions of histamine but at least
three diﬀerent types of neuronal ligand-gated ion channels are
modulated by histamine (Bekkers, 1993; Saras et al., 2008; Bianchi
et al., 2011; Kletke et al., 2013). The possible mechanism of the
modulation of GABAARs in the brain is still speculative (Saras
et al., 2008; Bianchi et al., 2011).
Currently, the interaction site for histamine on the GABAAR
is unknown. There are many known modulation sites on
the GABAARs for various compounds. These sites include
the amino acids β2(N265) and β2(M286). These two amino
acid residues are involved in the propofol and etomidate
interaction with the GABAARs (Krasowski et al., 2001; Siegwart
et al., 2002; Jurd et al., 2003; Reynolds et al., 2003). These
amino acid residues represent some of the diﬀerent modulation
mechanisms of the receptor. Propofol and etomidate are positive
modulators of the GABAARs. In addition to these described
modulation sites, there are other identiﬁed sites of functional
relevance. These sites are, e.g., the GABA-binding site, which
involves the amino acid residue F64 of the α subunit and
the amino acid residues Y157 and Y205 of the β subunits
(Sigel et al., 1992; Amin and Weiss, 1993). Recent studies
with mutated amino acids V175, Q185, and D163 of the β
subunit and R120 of the α subunit, which are components
of loop nine or are involved in a salt-bridge interaction,
show that these amino acids are involved in stabilizing the
closed state or involved in a state-dependent salt-bridge of
the GABAARs (Williams et al., 2010; Laha and Wagner,
2011).
While binding sites on the GABAARs have already been
described for some allosteric modulators, the molecular basis of
FIGURE 1 | GABA potentiated by histamine in wt receptors.
GABA-induced (EC10−30) currents are potentiated by 3 mM histamine.
(A–C) Xenopus oocytes expressing the abg isoforms: α1β2γ2L, α1β3γ2L,
and α2β3γ2L were voltage clamped, and GABA at a concentration of
10 μM was bath-applied with or without 3 mM histamine. (D) Average
potentiation of GABA-induced currents calculated from measurements as
shown in (A–C). Bars two to four show the mean enhancement ± SEM,
as a percentage of the amplitude of GABA alone (gray line), for the αβγ
isoforms: α1β2γ2L, α1β3γ2L, and α2β3γ2L, (n = 9–12). Significant data
were marked with ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.
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FIGURE 2 | Effect of 3 mM histamine on the GABA-induced current of
wt or mutated GABAARs. The bars show the increase of the GABA-induced
(typically EC10−30) currents by 3 mM histamine of the GABAAR subunit
combination (A) α1β2γ2L and (B) α2β3γ2L. Significant data were marked with
∗p ≤ 0.05 and ∗∗p ≤ 0.01.
positive allosteric receptor modulation by histamine is unknown.
Therefore, we plan to identify the amino acids that are involved
in the modulatory eﬀect of histamine at the GABAARs. For
that purpose, we investigated site-directed mutated GABAARs
expressed in a Xenopus laevis expression system using the two-
electrode voltage clamp technique, and analyzed the structural
impact of the chosen amino acids by creating a homology model
of a 2x α1 – 3x β3 GABAARs heteropentamer.
Materials and Methods
GABAAR cDNA
Expression plasmids based on the pSGEM vector (courtesy of
M. Hollmann, Bochum, Germany) for rat α1, β2, mouse γ2L,
and human β3 were described by Saras et al. (2008). Rat α2
cDNA was kindly provided by ImaGenes, Berlin, Germany, and
subcloned into pSGEM by using PCR and standard molecular
biology methods.
The point mutations were made using overlap-extension
PCRs, as described by Heckman and Pease (2007). For overlap-
extension PCRs, the plasmids for α1, β2, and β3 subunits
were used as templates. Overlap-extension PCR was performed
using a mixture of taq-DNA- and pwo-DNA-polymerase (20:1)
(Biotherm) in a volume of 50 μl with 20 pmol of each primer
(Supplementary Table S3). The following temperature cycle
proﬁle was used: 5 min at 95◦C; followed by 30 cycles of 45 s
at 95◦C, 45 s at 60◦C, 60 s at 72◦C (120 s for the fusion PCR);
and a ﬁnal extension of 10 min at 72◦C. The mutated DNA
was subcloned into pSGEM using standard molecular biology
methods.
Expression of Receptor cRNA in Xenopus
laevis oocytes
The cRNAs of wt as well as point mutated GABAAR subunit
cRNAs were synthesized by using the AmpliCap T7 high
yield message maker kit (Epicentre, Madison, WI, USA) as
described by Sergeeva et al. (2010). The oocytes were prepared
from Xenopus laevis using standard methods. Five to twenty
nanograms of cRNA was injected, 24 h after surgery, into
one stage V–VI oocyte. The incubation took place at 12–
16◦C in ND96 [96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2,
1 mM MgCl2, 5 mM HEPES, pH 7.2; 100 U/ml penicillin,
100 U/ml streptomycin from Antibiotic Antimycotic Solution
(100x)] (Sigma–Aldrich, St. Louis, MO, USA). After 2–4 days,
the oocytes were measured by two-electrode voltage clamp, as
brieﬂy described by Sergeeva et al. (2010). Each of the tested
substances was diluted with Frog-Ringer’s solution (115 mM
NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 10 mM HEPES, pH
7.2). The agonists were dissolved in ND96 and applied in a
volume of 200 μl into the entrance tube of the recording
chamber, totally exchanging the bath solution within a second.
Therefore, due to the relative slow desensitization kinetics
in our investigated GABA receptors and the fact that we
compare the same receptor ± histamine, desensitization will not
interfere with the determination of the histamine potentiation.
The pH of GABA- or histamine-containing solutions was
monitored to ensure a pH of 7.2 for all histamine concentrations.
All measurements were taken with a membrane potential of
−40 mV.
Analysis and Statistics
During the measurements, the currents were recorded
using CellWorks software and were analyzed using
pCLAMP 10 software. The statistical evaluation and
curve ﬁtting (3-parameter Hill equation) was performed
using SigmaPlot V8.0 (Systat Software, San Jose, CA,
USA). All mean values are ± SEM, and the signiﬁcant
data were marked with ∗p ≤ 0.05, ∗∗p ≤ 0.01, and
∗∗∗p ≤ 0.001.
GABAAR Homology Modeling and Histamine
Docking
The 2.97 Å crystal structure of the GABA β3 homopentamer
(Miller and Aricescu, 2014) was used as basis for homology
modeling. We carried out a sequence alignment of the α1
sequence (Uniprot entry P14867, The UniProt Consortium,
2013) and the β3 subunit sequences from the crystal structure
with MUSCLE (Edgar, 2004; default settings). The resulting
alignment showed 35.3% sequence identity and 61.9% sequence
similarity and is included in the Supplementary Material. As we
know from GPCR modeling, an identity >35% is a good basis
for homology modeling of transmembrane proteins (Wolf et al.,
2008; Kufareva et al., 2011). Based on this alignment, we created
and optimized a model of an α1 subunit homopentamer with
the SWISS-MODEL server (Biasini et al., 2014), based on the
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FIGURE 3 | Histamine action on GABA-induced currents of GABAARs
with the point mutated β2(Y157F) subunit. (A,D) Original traces of the
histamine (3 mM) action on the GABA-induced currents of the GABAARs
α1β2(Y157F)γ2L and α1β2(Y157F). (B,C,E,F) Bar diagrams show the
action of various histamine concentrations on the GABA-induced currents
of the GABAARs α1β2(Y157F)γ2L, α1β2(Y157F), α1β2γ2L, and α1β2.
Significant data were marked with ∗p ≤ 0.05, ∗∗p ≤ 0.01, and
∗∗∗p ≤ 0.001.
structure of the β3 homopentamer from the crystal structure
mentioned above. We then created a 2x α1 – 3x β3 GABAAR
heteropentamer by substituting two β3 subunits in the crystal
structure (chain A and C) by the respective α1 subunits in PyMol
(Schrödinger, 2010). We then carried out a WHATIF protein
check, showing that the model is reliable. The checkﬁle can
be found in the Supplementary Material. Binding site analysis
was carried out with TRIDOCK (te Heesen et al., 2007). In
short, TRIDOCK searches for putative binding positions for
small organic molecules following Congreve’s rule-of-three
(Congreve et al., 2003) and marks these positions with a “bead.”
Docking calculations on histamine binding were carried out with
Autodock Vina (Trott and Olson, 2010), using a 20 × 20 × 20 Å
box (grid spacing 1 Å) centered between Asp163(β) and R120(α),
and an exhaustiveness parameter of 80 (Schneider et al.,
2011). A histamine topology was obtained from the PRODRG
server (Schuttelkopf and van Aalten, 2004). Polar atoms
and Kollman charges were added to the heteropentameric
protein, while histamine was docked with Gasteiger
charges.
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FIGURE 4 | Histamine action on GABA-induced currents of GABAARs
with point mutated subunits α1(R120A) and β2(D163A). (A–C) Original
traces of the modulatory effect of 3 mM histamine on GABA-induced
currents from GABAARs α1(R120A)β2γ2L, α1β2(D163A)γ2L, and
α1(R120A)β2(D163A)γ2L. (D–F) Bar diagrams show the effect of 0.1 to
10 mM histamine on the GABA-induced (typically EC10−30) current.
Significant data were marked with ∗p ≤ 0.05, ∗∗p ≤ 0.01, and
∗∗∗p ≤ 0.001.
Results
Screening of Mutated GABAARs for Altered
Histamine Potentiation
Saras et al. (2008) showed that homomeric β2 or β3 receptors
were activated by histamine in a recombinant expression system.
Our intention was to analyze the eﬀect of histamine on point
mutated GABAAR β2/3 subunits. First, we generated mutations
in β2/3 subunits. In contrast to the wild-type (wt) subunits,
functional expression of mutated GABAARs as homomeric
receptors failed in most instances so that a systematic screening
of homomeric receptors was not possible. Therefore, we had to
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FIGURE 5 | Histamine action on the GABA-induced currents of
GABAARs with point mutated β3(V175A). (A) Original trace of the effect of
3 mM histamine on the GABA-induced currents of the GABAAR
α2β3(V175A)γ2L. (B) Bar diagram show the effect of various histamine
concentrations up to 10 mM on the GABA-induced currents of the GABAAR
α2β3(V175A)γ2L. Significant data were marked with ∗∗p ≤ 0.01.
determine the impact of mutated amino acids in heteromeric
receptors by analyzing the potentiating eﬀect of histamine on the
GABA-induced currents. We were mostly interested in the eﬀect
of histamine on the two most important synaptic GABAARs of
the CNS composed of α1β2γ2L and α2β3γ2L subunits (Pirker
et al., 2000; Nutt, 2006; Olsen and Sieghart, 2008).
To screen the modulating eﬀect of histamine, we investigated
the action of 3 mM histamine on currents evoked by GABA
(typically EC10−30). To determine suitable GABA concentrations
for screening experiments, the EC50 values of GABA for all
of the investigated subunit combinations were determined
(Supplementary Table S1). In addition, we tested histamine
concentrations up to 10 mM to demonstrate the absence of
homomeric GABAARs composed of β subunits. For all of our
analyzed GABAARs, histamine alone did not induce any currents
(data not shown).
First, we analyzed the wt GABAARs α1β2γ2L, α1β3γ2L,
and α2β3γ2L, to demonstrate a robust and reproducible
potentiation of GABA-induced currents by histamine under our
experimental conditions. This analysis also served as control for
our experiments with the point mutated GABAARs. With our
experiments, we could show, as Saras et al. (2008) had previously,
that histamine could increase the GABA-induced current of
wt receptors in a dose-dependent manner. Three millimolar
histamine signiﬁcantly potentiated the GABA-induced currents
of GABAARs α1β2γ2L by approximately 1.4-fold, α1β3γ2L by
approximately 0.6-fold and α2β3γ2L by approximately 0.7-fold
(Figure 1).
Next, we screened all point mutated GABAARs using the
same conditions: a GABA concentration of typical EC10−30
and a histamine concentration of 3 mM. The ﬁrst amino acids
to be analyzed for their action in the histamine modulation
of the GABAAR were the point mutants β(N265M) and
β(M286W). These amino acids are involved in the action of
etomidate and propofol on the GABAARs (Krasowski et al.,
2001; Siegwart et al., 2002; Jurd et al., 2003; Reynolds et al.,
2003). Our experiments showed that the GABA-induced
currents (10 μM GABA) on GABAARs that contained the
point mutated subunits β(N265M) or β(M286W) were
increased by histamine (Figure 2). However, the histamine
modulation of the mutated receptors was not signiﬁcantly
diﬀerent from the modulation of the wt GABAARs α1β2γ2L.
Therefore, these mutations do not inﬂuence histamine
modulation.
The next 10 amino acids that we analyzed are important
for binding GABA, for forming a state-dependent salt-bridge
or for stabilizing the closed state of the GABAARs (Amin and
Weiss, 1993; Williams et al., 2010; Laha and Wagner, 2011).
Furthermore, we were interested in the inﬂuence of the conserved
leucine in the pore-forming TM2 segment that is involved in
the gating-mechanism of the GABAARs (Chang and Weiss,
1999). Because this amino acid, β2(L259), is also present in
α subunits, we investigated point mutations of both a and β
subunits. Receptors with the mutations β2(Y157F), β2(D163A),
β3(V175A), and the combination of α1(R120A) with β2(D163A)
showed signiﬁcantly reduced potentiation of the GABA-induced
current by histamine (Figure 2).
It can be suggested that the amino acids Y157, D163, and
V175 of the β subunit and the amino acid R120 of the α subunit
are involved in the action of histamine. The analyzed GABAAR
α2β3(Q185A)γ2L showed a stronger potentiation than the wt
demonstrating that the amino acid Q185 also potentially aﬀects
histamine action on GABAARs.
Dose-Dependent Action of Histamine on
Mutated GABAARs
To investigate the impact of the identiﬁed amino acids on
histamine modulation in more detail, we next analyzed the eﬀect
of diﬀerent histamine concentrations (0.1 to 10 mM) on the
GABA-induced current (typically EC10−30).
The ﬁrst amino acid residue we analyzed was Y157 of
the β subunit. This amino acid residue is involved in the
conformational changes in the GABAARs induced by GABA
(Amin and Weiss, 1993). GABAAR α1β2(Y157F)γ2L showed
reduced potentiation of the GABA-induced current by 3 mM
histamine (Figure 2A) in comparison to the wt α1β2γ2L
receptor. Histamine concentrations of 0.1 to 10 mM potentiated
the GABA-induced current in a dose-dependent manner
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FIGURE 6 | Histamine action on the GABA-induced currents of
GABAARs with the point mutated β3(Q185A) subunit. (A) Original trace of
the histamine (3 mM) action on the GABA-induced (EC11) currents of the
GABAAR α2β3(Q185A)γ2L. (B,C) Bar diagrams that show the action of
different histamine concentrations on the GABA-induced currents of the
GABAARs α2β3(Q185A)γ2L and α2β3γ2L. Significant data were marked with
∗p ≤ 0.05 and ∗∗p ≤ 0.01.
(Figures 3A,B). However, for all of the tested concentrations,
the potentiating eﬀect was smaller than the eﬀect observed with
the wt receptor (Figures 3B,C, and Supplementary Table S2).
To analyze the inﬂuence of the γ2L subunit, we co-expressed
the subunits α1 and β2(Y157F). Histamine caused a dose-
dependent potentiation of the mutated GABAAR (Figures 3D,E)
that was not signiﬁcantly diﬀerent from the wt α1β2 receptor
(Figures 3E,F, and Supplementary Table S2). Interestingly, the
inﬂuence of the point mutations is dependent on the presence
of the γ2L subunit. These results show that Y157 is not essential
for potentiation by histamine.
Next, we analyzed the eﬀect of histamine on the amino
acids α1(R120) and β2(D163), which form a state-dependent
salt-bridge of the GABAARs (Laha and Wagner, 2011). We
investigated the ability of diﬀerent histamine concentrations (0.1
to 10 mM) to potentiate the GABA response (typically EC10−30)
on the GABAARs α1(R120A)β2γ2L, α1β2(D163A)γ2L, and
α1(R120A)β2(D163A)γ2L (Figure 4). Histamine shows a dose-
dependent potentiation on the GABAARs α1(R120A)β2γ2L and
α1β2(D163A)γ2L (Figures 4A,B,D,E). However, at a receptor
composed of both mutated subunits in combination with the
γ2L subunit, the increasing eﬀect of histamine is nearly abolished
(Figures 4C,F). In comparison to wt, the mutation α1(R120A)
alone had no signiﬁcant eﬀect on histamine potentiation
(Supplementary Table S2). At GABAARs α1β2(D163A)γ2L and
GABAAR α1(R120A)β2(D163A)γ2L (Figure 3C), histamine
potentiation was signiﬁcantly less than at the wt for most
concentrations tested (Supplementary Table S2). To ensure
that this eﬀect is speciﬁc to histamine and does not abolish
potentiation in general, we tested the potentiation of the GABA-
induced currents by 10 μMpropofol (Yip et al., 2013), which was
able to potentiate the GABA-induced current (data not shown).
To verify the inﬂuence of the γ2L subunit, we attempted to
express the subunit combinations α1(R120A)β2, α1β2(D163A),
and α1(R120A)β2(D163A), but none of these combinations
produced a functional receptor.
The last two amino acids that we analyzed were V175 and
Q185 on the β subunit. These amino acids are located in loop
9, which is in close proximity to the salt-bridge formed by
α1(R120A) and β2(D163A). The experiments with the GABAAR
α2β3(V175A)γ2L showed that the GABA-induced current was
not potentiated by histamine concentrations up to 3 mM
(0.1 to 3 mM; Figure 5). Only the highest concentration,
10 mM, signiﬁcantly changed the GABA-induced (EC16) current,
increasing it 1.4-fold (Figure 5B). In comparison to the wt
(Figure 6C), the potentiation eﬀected by histamine is drastically
reduced. This suggests that V175 is involved in the action of
histamine on the GABAARs. To demonstrate that this eﬀect is
not dependent on the presence of the α2 subunit, we tested
the α1β3(V175A)γ2L combination and also found a signiﬁcant
reduction in potentiation (Supplementary Figure S1). To ensure
that the loss of potentiation is speciﬁc for histamine, we tested
this mutated receptor with 10 μM propofol, which caused a
1.8-fold potentiation (data not show) demonstrating that GABA-
induced currents at this receptor can be potentiated by other
modulators.
In the initial screening, the potentiating eﬀect of histamine
appeared to be increased at GABAAR α2β3(Q185A)γ2L. The
investigation of various histamine concentrations (0.01 to
10 mM) revealed a dose-dependent potentiation of the GABA
(EC11) response (Figures 6A,B). In comparison to the wt
receptor (Figure 6C), where the ﬁrst signiﬁcant potentiation
was observed at 1 μM histamine, concentrations as low as
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FIGURE 7 | Overview of positions and functions of mutated residues.
Structural model based on PDB ID 4COF (Miller and Aricescu, 2014). Backbone
displayed as cartoon, van der Waals surface as surface, selected residues as
sticks, or balls and sticks, respectively. Extracellular domains visible as sheets,
transmembrane domains as helical domains. Putative binding positions of small
organic molecules according to TRIDOCK analysis (te Heesen et al., 2007) as
orange spheres and histamine in magenta. Y157 is actively taking part in
formation of the interface between the two subdomains. D163(β) and R120(α)
form a putative histamine binding site at the interface between subdomains α
and β. Q185 at the interface between transmembrane and extracellular domains
is part of a hydrogen bonding network with the highly conserved residues E52
and R216. The V175 side chain is buried within the extracellular subdomains,
and thus important for their correct folding. None of the investigated residues
except D163(β) and R120(α) show a putative small molecule binding site.
10 μM histamine produced signiﬁcant potentiation at the
α2β3(Q185A)γ2L receptor. For most concentrations up to 1mM,
histamine is a signiﬁcantly better potentiator at the mutated
receptor (Supplementary Table S2). At higher concentrations, the
eﬀect is no longer signiﬁcant, which is an indication that the
potency but not the eﬃcacy of histamine is enhanced by this
mutation. To demonstrate that this eﬀect is not dependent on
the presence of the α2 subunit, we tested the α1β3(Q185A)γ2L
subunit combination and also found a signiﬁcant increase in
potentiation (Supplementary Figure S1).
Discussion
Our study conﬁrms the recent ﬁnding (Saras et al., 2008;
Bianchi et al., 2011) that there is a robust modulatory eﬀect of
histamine on GABAARs with diﬀerent subunit combinations.
The screening of point mutated GABAAR subunits revealed that
most mutations, which encompass several amino acids conserved
in β subunits, did not inﬂuence histamine potentiation. Our
results demonstrate that the point mutations N265M and
M286W of amino acids in the β subunit that are important for the
modulation by etomidate and propofol (Siegwart et al., 2002; Jurd
et al., 2003; Reynolds et al., 2003) had no eﬀect on the modulation
of the GABA-induced current by histamine. Our results indicate
that histamine does not act through these known modulation
mechanisms.
In our work, we identiﬁed amino acid residues important for
the modulatory action of histamine on GABAARs. Four amino
acid residues are located on the β subunit, consistent with the
idea proposed by Saras et al. (2008) that the β subunit is involved
in the action of histamine at the GABAARs. Most recently, the
crystal structure of the human ß3 homopentameric receptor was
resolved (Miller and Aricescu, 2014). To assess the potential
function of the mutated amino acids, we build a homology model
of an α1/β3 heteropentamer (Figure 7).
The point mutation β2(Y157F) was only eﬀective in receptors
containing the γ2L subunit and did not alter histamine’s action
on receptors composed solely of a and β subunits. This indicates
that histamine does not directly interact with the amino acid
Y157. The presence of the γ2 subunit alters the potentiation by
histamine (Saras et al., 2008) and propofol (Siegwart et al., 2002).
An indirect participation could be caused by an inﬂuence of
amino acid Y157 on the interaction of γ2 with other subunits
in a heteromeric receptor. This is supported by the location
of Y157 in the homology model, as it is actively taking part
in formation of the interface between the two extracellular
subdomains (Figure 7).
A further amino acid residue that is involved in the
modulatory eﬀect of histamine is β3(Q185). This amino acid
has a potentially negative impact on histamine potentiation, and
the Q185A mutation enhances the eﬀect of lower concentrations
of histamine on the GABAAR. Q185 at the interface between
transmembrane and extracellular domains is part of a hydrogen
bonding network with the highly conserved residues E52 and
R216 (Figure 7). The amino acid V175 resides inside the
extra cellular domain and is of potential structural importance
(Figure 7). Therefore, the Q185A or V175A mutations inﬂuence
the histamine potentiation possibly by allosteric eﬀects and are
not part of a binding site.
The two amino acid residues that we identiﬁed as possibly
being directly involved in the action of histamine on the
GABAAR are R120 on the α subunit and D163 on the β subunit.
Amino acid R120 is conserved in all α subunits; therefore, our
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data could be valid for all α subunits. Laha and Wagner (2011)
showed that these amino acids could be part of a state-dependent
salt-bridge. This potential salt-bridge between R120 on the α
subunit and D163 on the β subunit stabilizes the binding of
GABA (Laha and Wagner, 2011). Disruption of the salt-bridge
on the α subunit by the R120A mutation greatly increases the
EC50 of GABA. The D163A mutation on the β subunit clearly
reduces histamine potentiation, and histamine potentiation is
nearly absent in receptors with the double mutation. Based on
our homology model, these two amino acid residues are not
close enough to form a salt bridge directly (Figure 7). However,
the crystal structure is derived from a homopentameric receptor
in a ligand bound state with the artiﬁcial agonist benzamidine.
Though this benzamidine binding site is found in the vicinity of
Y157 (Miller and Aricescu, 2014), it might inﬂuence the overall
structure of the extracellular domain, including the position of
R120. However, an analysis with TRIDOCK (te Heesen et al.,
2007) revealed that a putative small molecule ligand binding
site exists between D163 and R120 (Figure 7). Furthermore, our
docking analysis revealed that histamine can bind in various ways
at this site (see Figure 7 and Supplementary Figure 2) with a
comparably low predicted binding aﬃnity [G(bind) = −3.9
to –3.7 kcal/mol], which is in agreement with our comparably
low histamine aﬃnities measured experimentally. At the found
docking positions, the histamine ammonium headgroup interacts
majorly with D163(β), and thus probably weakens the R120/D163
interaction, which is in agreement with our experimental
results. Furthermore, the docking positions found are in good
agreement with the binding positions found by TRIDOCK.
This position therefore could be a binding site for histamine,
as well.
On the basis of our investigations, we suggest that histamine
interacts with D163 on the β subunit and weakens the interaction
of D163 with R120, which could lead to enhanced or prolonged
GABA binding, a left shift of the GABA EC50 and thereby to
potentiation. Consequently, we propose that the amino acid D163
is essential for the modulation of GABAARs by histamine and
possibly a part of the histamine binding site. We demonstrate
with our results a further function of the interaction of the α
and β subunit mediated by D163 with R120, which is vital for
both histamine potentiation and GABA aﬃnity. The amino acid
D163 is conserved in all β subunits of the GABAARs. In addition,
amino acids homologous to D163 could be detected in the α1
subunit of the GlyR and α7 subunit of the nAChRs (Galzi et al.,
1996; Newell et al., 2004). The homologous amino acid in the
nAChR is involved in the change of the aﬃnity for calcium and
acetylcholine (Galzi et al., 1996).
Conclusion
Our data show that histamine’s potentiation depends on amino
acid D163 of the β subunit and R120 of the α subunit.
Interaction of these amino acids lowers the EC50 for GABA
(Laha andWagner, 2011). We propose that histamine potentiates
GABAARs by inﬂuencing this interaction and that these amino
acids are part of a potential histamine binding site.
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